
|Articles|May 5, 2021
Precise Control with Improved Drug Delivery
Author(s)Adare Pharma Solutions
In pharma delivery, size matters. So, too, do the intricacies of dosage format, active ingredient compatibility, and effective delivery to patients—whatever their needs or preferences may be. Yet standard dosage forms haven’t always provided companies the options, flexibility, or performance to bring all those puzzle pieces together during therapeutic development. We spoke with Nathan H. Dormer, PhD, Director of Drug Product Development at Adare Pharma Solutions, to learn how this new technology platform is expanding the frontiers of therapeutic delivery and improving patients’ experience in the process.
Trending on Pharmaceutical Technology
1
Ask the Expert: Complying with Standards
2
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
3
How the Nitrosamine Guidance Shift is Changing LC-MS Workflows for APIs and Peptides
4
Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models
5